Recent advances in the management of primary sclerosing cholangitis

K. D. Lindor, R. H. Wiesner, Nicholas F La Russo

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by fibrosing inflammation of the biliary tract. Bile duct obstruction, biliary cirrhosis, and hepatic failure may follow. The disease is often associated with chronic ulcerative colitis and must be distinguished from bile duct abnormalities arising from choledocholithiasis, previous biliary tract operations, congenital malformations, and cholangiocarcinoma. The widespread availability of endoscopic retrograde cholangiography beginning in the 1970s has led to the recognition of a progressively larger number of patients with PSC and has contributed to the rapid growth of knowledge about its clinical, radiographic, and histologic features. Advances have also been made in understanding the pathogenesis and treatment of PSC. Currently, the cause of PSC remains unknown, although alterations in immunologic function are most often implicated. No treatment has been proved to be beneficial in PSC; however, a number of exciting new developments have appeared on the horizon.

Original languageEnglish (US)
Pages (from-to)322-327
Number of pages6
JournalSeminars in Liver Disease
Volume7
Issue number4
StatePublished - 1987

Fingerprint

Sclerosing Cholangitis
Biliary Tract
Choledocholithiasis
Cholangiocarcinoma
Cholangiography
Biliary Liver Cirrhosis
Cholestasis
Liver Failure
Bile Ducts
Ulcerative Colitis
Liver Diseases
Inflammation
Therapeutics
Growth

ASJC Scopus subject areas

  • Hepatology

Cite this

Recent advances in the management of primary sclerosing cholangitis. / Lindor, K. D.; Wiesner, R. H.; La Russo, Nicholas F.

In: Seminars in Liver Disease, Vol. 7, No. 4, 1987, p. 322-327.

Research output: Contribution to journalArticle

@article{64fb4f8e18594408bbc92e440572f1ec,
title = "Recent advances in the management of primary sclerosing cholangitis",
abstract = "Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by fibrosing inflammation of the biliary tract. Bile duct obstruction, biliary cirrhosis, and hepatic failure may follow. The disease is often associated with chronic ulcerative colitis and must be distinguished from bile duct abnormalities arising from choledocholithiasis, previous biliary tract operations, congenital malformations, and cholangiocarcinoma. The widespread availability of endoscopic retrograde cholangiography beginning in the 1970s has led to the recognition of a progressively larger number of patients with PSC and has contributed to the rapid growth of knowledge about its clinical, radiographic, and histologic features. Advances have also been made in understanding the pathogenesis and treatment of PSC. Currently, the cause of PSC remains unknown, although alterations in immunologic function are most often implicated. No treatment has been proved to be beneficial in PSC; however, a number of exciting new developments have appeared on the horizon.",
author = "Lindor, {K. D.} and Wiesner, {R. H.} and {La Russo}, {Nicholas F}",
year = "1987",
language = "English (US)",
volume = "7",
pages = "322--327",
journal = "Seminars in Liver Disease",
issn = "0272-8087",
publisher = "Thieme Medical Publishers",
number = "4",

}

TY - JOUR

T1 - Recent advances in the management of primary sclerosing cholangitis

AU - Lindor, K. D.

AU - Wiesner, R. H.

AU - La Russo, Nicholas F

PY - 1987

Y1 - 1987

N2 - Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by fibrosing inflammation of the biliary tract. Bile duct obstruction, biliary cirrhosis, and hepatic failure may follow. The disease is often associated with chronic ulcerative colitis and must be distinguished from bile duct abnormalities arising from choledocholithiasis, previous biliary tract operations, congenital malformations, and cholangiocarcinoma. The widespread availability of endoscopic retrograde cholangiography beginning in the 1970s has led to the recognition of a progressively larger number of patients with PSC and has contributed to the rapid growth of knowledge about its clinical, radiographic, and histologic features. Advances have also been made in understanding the pathogenesis and treatment of PSC. Currently, the cause of PSC remains unknown, although alterations in immunologic function are most often implicated. No treatment has been proved to be beneficial in PSC; however, a number of exciting new developments have appeared on the horizon.

AB - Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by fibrosing inflammation of the biliary tract. Bile duct obstruction, biliary cirrhosis, and hepatic failure may follow. The disease is often associated with chronic ulcerative colitis and must be distinguished from bile duct abnormalities arising from choledocholithiasis, previous biliary tract operations, congenital malformations, and cholangiocarcinoma. The widespread availability of endoscopic retrograde cholangiography beginning in the 1970s has led to the recognition of a progressively larger number of patients with PSC and has contributed to the rapid growth of knowledge about its clinical, radiographic, and histologic features. Advances have also been made in understanding the pathogenesis and treatment of PSC. Currently, the cause of PSC remains unknown, although alterations in immunologic function are most often implicated. No treatment has been proved to be beneficial in PSC; however, a number of exciting new developments have appeared on the horizon.

UR - http://www.scopus.com/inward/record.url?scp=0023621314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023621314&partnerID=8YFLogxK

M3 - Article

C2 - 3324352

AN - SCOPUS:0023621314

VL - 7

SP - 322

EP - 327

JO - Seminars in Liver Disease

JF - Seminars in Liver Disease

SN - 0272-8087

IS - 4

ER -